Hjem › Melanom › Arizona › Scottsdale
Kliniske studier for Melanom i Scottsdale, AZ
10 studier for Melanom søker deltakere på steder i og rundt Scottsdale (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RekruttererFase 1/2
- HonorHealth Research Institute, Scottsdale
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
RekruttererFase 1/2
- Arizona State University-Honor Health Research Institute, Scottsdale
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
RekruttererFase 1/2
- HonorHealth Research Institute, Scottsdale
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RekruttererFase 3
- Mayo Clinic Scottsdale - PPDS, Scottsdale
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruttererFase 2/3
- HonorHealth Research Insisute, Scottsdale
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RekruttererFase 1/2
- HonorHealth Research and Innovation Institute, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
RekruttererFase 1/2
- Mayo Clinic in Arizona, Scottsdale
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- HonorHealth Research Institute, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RekruttererFase 1
- HonorHealth Research Institute, Scottsdale
Melanom-studier i andre byer
- Houston, TX59 studier
- New York City, NY38 studier
- Los Angeles, CA34 studier
- Nashville, TN33 studier
- Pittsburgh, PA31 studier
- Boston, MA26 studier
- Philadelphia, PA23 studier
- San Francisco, CA22 studier
- Columbus, OH21 studier
- Durham, NC21 studier
- Atlanta, GA21 studier
- Salt Lake City, UT21 studier
Andre studier i Scottsdale
- Brystkreft18 studier
- Kreft (alle typer)18 studier
- Metastatisk kreft17 studier
- Prostatakreft17 studier
- Kolorektal kreft16 studier
- Ikke-småcellet lungekreft15 studier
- Pankreaskreft13 studier
- Ulcerøs kolitt8 studier
- Lungekreft8 studier
- Leverkreft (hepatocellulært karcinom)7 studier
- Alzheimers sykdom7 studier
- Tripelnegativ brystkreft7 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.